Medicare Enrolled

Dr. Scott Beeve, MD

Ophthalmology · Glendale, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1809 VERDUGO BLVD, Glendale, CA 91208
8187908001
In practice since 2006 (19 years)
NPI: 1821176769 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beeve from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beeve? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beeve

Dr. Scott Beeve is an ophthalmology specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Beeve performed 4,230 Medicare services across 3,224 unique beneficiaries.

Between the years covered by Open Payments, Dr. Beeve received a total of $5,627 from 37 pharmaceutical and/or device companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beeve is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in CA $5,627 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,230
Medicare services
Top 24% in CA for ophthalmology
3,224
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~223 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
842 $67 $120
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
706 $29 $125
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
621 $89 $170
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
229 $48 $135
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
207 $463 $2,000
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
199 $133 $230
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
195 $26 $140
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
181 $285 $600
Aflibercept eye injection (Eylea) 166 $694 $1,150
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
115 $32 $140
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
114 $53 $133
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
98 $207 $700
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
97 $92 $198
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
92 $100 $198
New patient office visit, complex (60-74 min) 89 $150 $340
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
76 $23 $75
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
71 $101 $200
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
62 $12 $65
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
26 $48 $142
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
22 $6 $30
Eye photography
Photographic imaging of the interior structures of the eye.
22 $19 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
16.8% medium
78.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,627
Total received (2018-2024)
Avg $804/year across 7 years
Top 23% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,627 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,178
2023
$945
2022
$987
2021
$723
2020
$633
2019
$737
2018
$424

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$345
Alcon Vision LLC
$166
Regeneron Healthcare Solutions, Inc.
$162
Oyster Point Pharma, Inc.
$149
ABBVIE INC.
$86
Bausch & Lomb Americas Inc.
$37
Sight Sciences, Inc.
$34
Tarsus Pharmaceuticals, Inc.
$29
Dompe US, Inc.
$28
Harrow Eye, LLC
$26
Apellis Pharmaceuticals, Inc.
$26
Genentech USA, Inc.
$22
RxSight Inc
$21
Thea Pharma Inc.
$16
Johnson & Johnson Surgical Vision, Inc.
$15
BIOTISSUE HOLDINGS INC.
$15
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$659
Allergan, Inc.
$645
Novartis Pharmaceuticals Corporation
$581
Alcon Vision LLC
$528
SUN PHARMACEUTICAL INDUSTRIES INC.
$454
Shire North American Group Inc
$393
Regeneron Healthcare Solutions, Inc.
$348
Oyster Point Pharma, Inc.
$320
ABBVIE INC.
$213
Glaukos Corporation
$195
AbbVie Inc.
$131
Aerie Pharmaceuticals, Inc.
$116
Genentech USA, Inc.
$94
Eyevance Pharmaceuticals LLC
$89
Bausch & Lomb Americas Inc.
$78
Mallinckrodt Hospital Products Inc.
$71
Kala Pharmaceuticals, Inc.
$63
Dompe US, Inc.
$61
Bausch & Lomb, a division of Bausch Health US, LLC
$54
Alcon Laboratories Inc
$54
Johnson & Johnson Surgical Vision, Inc.
$51
Allergan Inc.
$47
EYEVANCE PHARMACEUTICALS LLC
$44
Sight Sciences, Inc.
$34
Thea Pharma Inc.
$33
OPTOS, INC.
$33
Tarsus Pharmaceuticals, Inc.
$29
Harrow Eye, LLC
$26
Apellis Pharmaceuticals, Inc.
$26
Horizon Therapeutics plc
$24
BioTissue Holdings, Inc.
$24
EyePoint Pharmaceuticals US, Inc.
$21
RxSight Inc
$21
Carl Zeiss Meditec AG
$19
Ivantis, Inc
$15
BIOTISSUE HOLDINGS INC.
$15
Boston Scientific Corporation
$13
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALREX · ARGOS · AcrySof IQ PanOptix · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · Cequa · Clareon · DEXYCU · DURYSTA · EYLEA · EYLEA HD · Flarex · HYDRUS Microstent · Hydrus Microstent · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · LOTEMAX · LOTEMAX SM · LUMIGAN · Lucentis · MIEBO · None Specified · OMNI SURGICAL SYSTEM · OXERVATE · P200DTx · PROKERA · PanOptix · Photrexa · Precision 1 · RESONATE · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rocklatan · Simbrinza · Syfovre · TEARCARE SYSTEM · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · TobraDex ST · Tobradex ST · VEVYE · VUITY · Vabysmo · XDEMVY · XELPROS · XIIDRA · ZERVIATE · iStent Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Glendale?
Compare ophthalmologists in the Glendale area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
719
Per 100K population
7.3
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beeve is a mixed practice specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beeve experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Beeve performed 842 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beeve receive payments from pharmaceutical companies?
Yes. Dr. Beeve received a total of $5,627 from 37 companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beeve's costs compare to other ophthalmologists in Glendale?
Dr. Beeve's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beeve) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →